AlphaFold predicted structure
PRKRA · O75569

Mean pLDDT
75.4/ 100
Confident
313 residues
Confidence breakdown
- Very high(≥ 90)33%
- Confident(70–90)38%
- Low(50–70)11%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein activator of interferon induced protein kinase EIF2AK2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Adult onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalEarly onset dystonia
BIALLELIC, autosomal or pseudoautosomalParkinson Disease and Complex Parkinsonism
BIALLELIC, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomaldystonia 16
Dystonia
psoriasis
atopic eczema
hereditary disease
hepatocellular carcinoma
conduction system disorder
pachyonychia congenita
autism
auriculocondylar syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interferon-inducible double-stranded RNA-dependent protein kinase activator A
Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53 association and sumoylation and phosphorylation of p53/TP53 at 'Lys-386' at 'Ser-392' respectively and enhances its activity in a EIF2AK2/PKR-dependent manner (By similarity). May function as regulator of gastric epithelial differentiation (By similarity)
PRKRA · O75569

Mean pLDDT
75.4/ 100
Confident
313 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0